Pfizer Q4 Results
- BSE: 500680
- NSE: PFIZER
- ISIN: INE182A01018
- Sector: Major Drugs
BSE
4,709.35
-109.50 (-2.27%)
-109.50 (-2.27%)Volume755.00
Updated: Wed 11 Mar, 2026 | 15:28:03
NSE
4,700-103.50 (-2.15%)
-103.50 (-2.15%)Volume17.19 K
Updated: Wed 11 Mar, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Pfizer Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 380.81 | 489.30 | -6.39% | 370.95 | 2.66% |
| Depreciation/ Amortization | 16.40 | 14.26 | 10.81% | 13.75 | 19.27% |
| Operating Income | 211.10 | 155.73 | 60.91% | 175.68 | 20.16% |
| Net Income | 330.94 | 141.84 | 159.36% | 178.86 | 85.03% |
| Other Operating Expenses Total | 79.02 | 91.77 | -20.30% | 92.75 | -14.80% |
| Net Income Before Taxes | 425.80 | 191.95 | 146.93% | 243.86 | 74.61% |
| Total Revenue | 591.91 | 645.03 | 10.02% | 546.63 | 8.28% |
| Selling/ General/ Admin Expenses Total | 82.91 | 100.30 | -13.90% | 75.11 | 10.38% |
| Diluted Normalized EPS | 42.99 | 40.41 | 54.16% | 39.09 | 10.00% |